Sunny Pharmtech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	77.93	138.02	270.56	222.63	229	241.72
Short-Term Investments	-	-	-	48.51	12.5	-
Cash & Short-Term Investments	77.93	138.02	270.56	271.14	241.5	241.72
Cash Growth	-64.77%	-48.98%	-0.21%	12.27%	-0.09%	-28.22%
Accounts Receivable	57.13	49.34	56.35	28.77	63.63	39.18
Other Receivables	0.51	2.26	0.8	1.78	7.17	10.29
Receivables	57.63	51.6	57.15	30.55	70.8	49.47
Inventory	140.39	123.49	97.04	71.94	97.6	140.38
Prepaid Expenses	42.87	48.64	28.65	21.75	18.4	15.07
Other Current Assets	3.3	3.1	7.1	18.6	43.48	2.4
Total Current Assets	322.12	364.86	460.49	413.98	471.78	449.03
Property, Plant & Equipment	1,042	1,092	1,156	1,102	946.12	910.26
Goodwill	25.24	25.24	25.24	25.24	25.24	25.24
Other Intangible Assets	34.65	35.96	42.77	55.2	51.42	58.73
Other Long-Term Assets	36.92	69.2	27.91	32.76	100.16	56.34
Total Assets	1,494	1,587	1,712	1,630	1,595	1,500
Accounts Payable	31.41	16.88	26.13	12.34	23.17	17.22
Accrued Expenses	26.95	44.8	30.43	23.81	21.9	21.6
Short-Term Debt	84	20	-	190	50	46.72
Current Portion of Long-Term Debt	20.75	20.75	11.19	9.44	20.09	32.83
Current Portion of Leases	4.1	4.17	3.94	3.16	2.79	2.76
Current Unearned Revenue	39.45	32.5	19.19	12.48	10.87	7.19
Other Current Liabilities	40.57	25.85	20.95	29.03	36.89	16.49
Total Current Liabilities	247.21	164.94	111.83	280.25	165.7	144.81
Long-Term Debt	286.69	297.06	333.81	327.24	264.44	269.94
Long-Term Leases	42.25	44.31	42.49	32.86	28.98	31.77
Long-Term Unearned Revenue	15.63	27.13	17.07	12.74	1.46	1.46
Other Long-Term Liabilities	7.24	7.24	7.24	7.24	7.68	7.24
Total Liabilities	599.02	540.68	512.44	660.32	468.26	455.21
Common Stock	1,488	1,488	1,485	1,385	1,385	1,295
Additional Paid-In Capital	22.39	21.69	209.53	16.9	169.06	2.88
Retained Earnings	-615.76	-462.96	-496.17	-432.85	-427.84	-253.05
Comprehensive Income & Other	-	0.41	1.32	-	-	-
Shareholders' Equity	894.85	1,047	1,200	969.3	1,126	1,044
Total Liabilities & Equity	1,494	1,587	1,712	1,630	1,595	1,500
Total Debt	437.79	386.29	391.43	562.69	366.3	384.01
Net Cash (Debt)	-359.86	-248.27	-120.87	-291.55	-124.8	-142.29
Net Cash Per Share	-2.42	-1.67	-0.85	-2.10	-0.93	-1.10
Filing Date Shares Outstanding	148.82	148.76	148.53	138.53	138.53	129.46
Total Common Shares Outstanding	148.82	148.76	148.53	138.53	138.53	129.46
Working Capital	74.91	199.92	348.66	133.74	306.08	304.23
Book Value Per Share	6.01	7.04	8.08	7.00	8.13	8.07
Tangible Book Value	834.96	985.49	1,132	888.86	1,050	960.42
Tangible Book Value Per Share	5.61	6.62	7.62	6.42	7.58	7.42
Buildings	857.75	856.04	847.93	777.39	702.81	673.73
Machinery	863.77	856.02	822.27	587.06	512.13	471.67
Construction In Progress	-	2.69	4.44	162.91	64.94	7.5

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.